Clicky

ChromaDex Corporation(OCD1)

Description: ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.


Keywords: Consumer Products Dietary Supplement E Commerce Platform Chromadex Ingredient Technologies

Home Page: www.chromadex.com

10900 Wilshire Blvd
Los Angeles, CA 90024
United States
Phone: 310 388 6706


Officers

Name Title
Mr. Frank Louis Jaksch Jr. Co-Founder & Chairman
Mr. Robert N. Fried CEO & Director
Mr. Ozan Pamir C.F.A. CFO & Principal Accounting Officer
Dr. Andrew Shao Ph.D. Senior Vice President of Global Regulatory & Scientific Affairs
Mr. Carlos Lopez Senior VP & General Counsel
Alex Worsham Vice President of Global Marketing & Communications
Ms. Michiko Kelley Chief Marketing Officer
Ms. Chu Yan Managing Director of Asia Pacific
Kendall Knysch Head of Media Relations & Partnerships
Mr. James Lee Controller

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 52.6316
Trailing PE: 322.5
Price-to-Book MRQ: 15.1738
Price-to-Sales TTM: 5.3745
IPO Date:
Fiscal Year End: December
Full Time Employees: 106
Back to stocks